Efficacy and safety of artesunate for the treatment of severe malaria in Europe

T. Zoller, T. Junghanss, A. Kapaun, I. Gjörup, J. Richter, M. Hugo-Persson, N. Suttorp, S. Yürek & H. Flick
Background: Large multicenter trials from South-East Asia have demonstrated an improved survival for i.v.-artesunate as compared to quinine for the treatment of severe malaria. For patients with severe malaria in Europe, quinine is still the mainstay of treatment and artesunate has not been evaluated[for full text, please go to the a.m. URL]